Story
The Full Story
DAQO's story is a textbook commodity cycle compressed into six years: from a $300M-revenue mid-tier producer (2018) to a $4.6B profit machine (2022) to a loss-making survivor betting everything on Chinese government intervention (2025-2026). Management's narrative shifted from "growth and expansion" to "lowest-cost survivor" to "policy beneficiary" — each pivot was forced by prices, not chosen proactively. Their credibility rests on two things they delivered: industry-leading costs and a fortress balance sheet. What they didn't deliver: any guidance on timing the cycle turn.
The Narrative Arc
The market cap peaked in 2020 ($4.2B) — before revenue peaked in 2022 ($4.6B). The stock was already declining as revenue was still surging, because the market correctly priced in the inevitable capacity overshoot. By FY2025, with revenue at $665M and losses mounting, the stock rallied to $29.50 on policy hopes — pricing the narrative, not the numbers.
What Management Emphasized — and Then Stopped Emphasizing
Missing required column(s): undefined not found in data set.
Constant theme: "Lowest-cost producer" appears in every single call — this is the anchor identity. Management never wavers from this claim.
Risen themes: "Anti-involution" went from nonexistent to the dominant narrative in 12 months. By Q4 FY2025, management frames the entire outlook around government price floors. "Balance sheet strength" intensified as losses mounted — pivoting from a secondary talking point to the core survival argument.
Dropped themes: "Capacity expansion" disappeared after Q4 FY2024. In 2021-2023, every call featured expansion milestones (Phase 4B, 5A, 5B). By 2025, expansion is never mentioned — replaced by "maintaining utilization at 50-55%." The buyback program, emphasized in FY2022-2023, went silent after FY2024.
New stretch: "Space-based solar power" appeared in Q4 FY2025 as a future demand driver for polysilicon — a speculative talking point that signals management is reaching for long-term narratives as near-term fundamentals remain challenging.
Risk Evolution
Missing required column(s): undefined not found in data set.
The most important evolution: policy dependency emerged from nothing (2021-2023) to the dominant risk factor (2025). DAQO's thesis now hinges on a government body enforcing minimum prices — a dependency that didn't exist three years ago. Overcapacity went from background concern (2021) to existential threat (2024-2025). Customer concentration quietly worsened: the top customer reached 38.9% of FY2025 revenue, up from ~23% in prior years.
How They Handled Bad News
Management handled the downturn with unusual candor for a Chinese-listed company. They acknowledged losses directly, did not sugarcoat utilization cuts, and provided specific cost and price figures that investors could verify.
Q2 FY2024 (first major loss quarter): Management acknowledged "prices have fallen below cash costs for most producers" and proactively cut utilization to 55%. No attempt to hide the severity.
Q4 FY2024 ($176M asset impairment): Ming Yang disclosed the impairment was for "older polysilicon production lines" and explained it transparently. However, concentrating the charge in one quarter (rather than gradual write-downs) enables cleaner future margins.
Q1 FY2026 ($27M revenue on 4,500 MT sold): This was the most revealing call. Management admitted to deliberately withholding product from the market, waiting for government price guidance. Ming Yang stated frankly: "If there's no enforcement, then we maybe need to sell wherever the market is." This level of directness about strategic uncertainty is unusual.
Management's strongest credibility signal: they never claimed to know when the cycle would turn. Every call included some variant of "we do not have visibility" on timing. This honesty, while frustrating for investors, builds trust relative to peers who offer false precision.
Guidance Track Record
Management Credibility Score (1-10)
Credibility score: 6.5 / 10. Production guidance has been consistently met or nearly met — the operational team executes well. Capex ran over guidance in FY2025, reflecting typical construction overruns. The critical unmet promise is the price floor narrative: management has repeatedly cited RMB 53-54/kg as a policy-supported minimum, but as of Q1 FY2026, market prices remain at RMB 35-37/kg. This gap between stated expectation and market reality is the single biggest credibility risk.
What the Story Is Now
The current story is simple: DAQO is the last-man-standing play in Chinese polysilicon. Management frames the company as one of the lowest-cost, highest-quality producers with the strongest balance sheet, positioned to survive a shakeout that will eliminate weaker competitors and restore pricing power.
What has been de-risked: The balance sheet survived the trough without taking debt. Cash costs reached record lows ($4.46/kg). The Inner Mongolia capacity is built. The N-type product transition is largely complete. Losses have narrowed sharply from FY2024 to FY2025.
What still looks stretched: The entire recovery thesis depends on Chinese government enforcement of price floors — a dependency that management acknowledges is uncertain. The June 2026 cost-model guidance is the next key milestone, but enforcement mechanisms remain undefined. The "space-based solar for AI data centers" talking point suggests management is grasping for long-term growth narratives beyond the current cycle.
What to believe versus discount: Believe the cost position and balance sheet data — these are verified quarterly and have been consistently accurate. Believe that management will preserve cash and avoid irrational behavior. Discount the policy timeline — management's expectation for June 2026 price guidance may slip, as previous policy milestones have been delayed. Discount the M&A/consolidation narrative — management has been "completely open-minded" about acquisitions since Q4 FY2025 but has taken no concrete action.